共 50 条
- [21] The Safety and Efficacy Of Tocilizumab Subcutaneous In Combination With Traditional Dmards In Patients With Moderate To Severe Rheumatoid Arthritis Up To 48 Weeks (BREVACTA). ARTHRITIS AND RHEUMATISM, 2013, 65 : S604 - S605
- [22] Tocilizumab in the treatment of rheumatoid arthritis and beyond DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 349 - 364
- [26] Review of tocilizumab in the treatment of rheumatoid arthritis BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 75 - 82
- [29] Abatacept: A novel treatment for moderate-to-severe rheumatoid arthritis PHARMACOTHERAPY, 2007, 27 (12): : 1693 - 1701